Publication | Closed Access

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

Neuro-oncologyThrombosisGliomaMedicineHematologyClinical TrialsMalignant GliomaAnticoagulantNeurologyCancer TreatmentOncologyRadiation OncologyHealth Sciences